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Tuberculosis (TB) is well known as a diagnostic chameleon and can resemble malignancy. In thorax TB
can be manifested as pulmonary inﬁltrates and/or mediastinal lymphadenopathy. In low incident
countries with high incidence of lung cancer and varying clinical presentations, TB often gets mis-
diagnosed with the result of delayed treatment start and unnecessary diagnostic procedures.
Our case report presents two patients, who were referred to the Thorax diagnostic centre at the
Department of Respiratory Medicine, Odense University Hospital, with presumptive diagnosis of
neoplasm and had proved lung TB with no evidence of malignancy instead. In the ﬁrst case diagnosis was
conﬁrmed after thoracotomy, in the second case after bronchoscopy.
© 2015 The Author. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Tuberculosis (TB) is well known as a diagnostic chameleon and
can also resemble malignancy. In thorax TB can be manifested as
pulmonary inﬁltrates and/or mediastinal lymphadenopathy. Since
the discovery of Mycobacterium tuberculosis by R. Koch, world
medical organisations put a big effort into different programs,
trying to eliminate TB. Nevertheless it remains a major global
health problem. It ranks as the second leading cause of death from
an infectious disease worldwide, after the human immunodeﬁ-
ciency virus (HIV) [1]. The latest estimates reported 8.6 million new
TB cases in 2012 and 1.3 million TB deaths (just under 1.0 million
among HIV-negative people and 0.3 million HIV-associated TB
deaths) [1]. In 2012 the TB incidence rate per 100.000 population in
theWest Europewas reported between 15 (UK) and 3.5 (Iceland). In
Denmark the incidence rate was reported to be 7.4, and there were
410 TB cases per year.
Due to the reduction of TB incidence in the western countries
and varying clinical presentations, resulting in unnecessary diag-
nostic testing and delayed treatment start.
2. Case reports
2.1. Case 1
A 48-year-old man was referred with a 2 month history of chest
tightness, intermittent non-productive cough and unintendedtd. This is an open access article uweight loss of 3 kg in the past 2 month. He had no reported fever
and had no prior medical history. He smoked around 30 cigarettes
per day and had estimated 45 pack years.
Physical examination revealed no abnormalities. Routine lab-
oratory investigations, including leukocytes (L) and C-reactive
protein (CRP) presented normal values. The lung functions tests
showed normal ventilation parameters with forced expiratory
volume in 1 s (FEV1) of 3.5 l (94% of the predicted value) and
forced vital capacity (FVC) of 4.5 l (97% of the predicted value).
The chest X-ray presented an approximately 2 cm nodular inﬁl-
trate in the left lung (Fig. 1). Computed tomography (CT) scan of
the chest conﬁrmed inﬁltrate in segment 6 of the left lower lobe
(Fig. 2). Under the presumptive diagnosis of malignancy we or-
dered a whole-body 18 ﬂour-deoxyglucose positron emission
tomography (18-FDG-PET) and CT scan. It revealed a high meta-
bolic activity of the lesion (Fig. 3). With this imaging appearance,
a provisional diagnosis of lung cancer was made. The patient
underwent bronchoscopy with brush biopsies, endobronchial
ultrasound transbronchial needle aspiration (EBUS eTBNA) and
CT-guided lung biopsy with negative result concerning malig-
nancy and without any diagnostically clariﬁcation. We still
considered that the patient has lung cancer, so the next step was
Video-assisted thoracoscopic surgery (VATS). The pathologic ex-
amination revealed no malignancy but instead caseous granulo-
matous inﬂammation. PCR for mycobacterium TB complex taken
from the resected lung tissue was positive, so the diagnosis of
pulmonary TB was conﬁrmed, and the patient received standard
anti-TB-therapy composed of pyrazinamide, isoniazid, etham-
butol and rifampicin.nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Chest X-ray showing inﬁltrate in the left lung.
Fig. 2. CT thorax showing inﬁltrate in the left upper lobe.
Fig. 3. 18-FDG-PET scan showing high metabolic activity.
Fig. 4. Chest X-ray showing inﬁltrate in the right lung.
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A 56-year-old manwith a 12 month history of productive cough,
thorax pain related to respiration and around 10 kg unintended
weight loss was referred to our department with a presumptive
diagnosis of lung cancer. He smoked up to 60 cigarettes per dag andhad estimated 100 pack/years. Routine laboratory investigations,
including L and CRP revealed no abnormalities. He was diagnosed
with COPD and lung function tests showed FEV1 over 2.2 l (59% of
predicted value) and FVC over 3.7 l (79% of predicted value). He had
a family history of lung cancer and had a history of alcohol over-
consumption. Chest X-ray showed consolidation in the upper right
lobe (Fig. 4) and the CT scan revealed an inﬁltrate with cavitations
and irregular margins (Fig. 5). The patient underwent 18-FDG-PET
and CT scan with the result of high metabolic activity of the lesion
(Fig. 6). The next diagnostic step was bronchoscopy with brush and
forceps biopsies with negative results concerning malignancy. We
Fig. 5. CT thorax showing inﬁltrate in the right upper lobe.
Fig. 6. 18-FDG-PET scan showing high metabolic activity.
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with negative results concerning bacteria, fungi, legionella, myco-
plasma, chlamidiae, negative direct microscopy and PCR for
mycobacterium TB complex. Only cultivation of the bronchial wash
provided the diagnosis by documented growth of the mycobacte-
rium TB. The patient was started on standard anti-TB-therapy.
3. Discussion
TB and lung cancer have been confused and misdiagnosed for
centuries [2]. There is especially in countries with low TB incidence
diagnostic challenges with risk of diagnosis getting missed.
Radiological features suggestive of lung cancer, like consolidations
with irregular margins and thick-walled cavities, showing high
metabolic activity on the 18-FDG-PET and CT-imaging are also
typical for lung tuberculosis. Differentiation according to the
radiological ﬁndings can not be provided. The diagnosis has to be
conﬁrmed by pathological and microbiological tests.
Prytz et al. reported about 91 patients with presumptive diag-
nosis of lung cancer, who underwent thoracotomy, but proved to
have pulmonary TB [2].
Pitlik et al. reported about 26 cases out of more than 70.000
patients, who were referred to the Texas cancer centre, USA during
the 10 year period (1973e1982), with presumptive diagnosis of
neoplasm and had bacteriological proved TB with no evidence of
malignancy [3]. Classic symptoms, connected to TB, like fever,haemoptysis and weight loss were uncommon [3]. The most
common abnormalities on chest radiography were multilobar
inﬁltration, upper lobes inﬁltrates and pleural effusion [3]. The
most common form was pulmonary TB followed by lymphadenitis
[3]. Laboratory abnormalities were unusual [3].
Rolston et al. conducted a retrospective analysis, covering a 3-
year period, of patients with presumed lung cancer, who turned
out to have pulmonary infection instead. Of the 2908 patients who
underwent a diagnostic evaluation, 2713 (93%) were documented
as having either a primary or a metastatic pulmonary lesion; 11
patients (0.4%) had a benign process; 37 patients (1.3%) had a
documented infection; and 147 patients (5.0%) had nonspeciﬁc
ﬁndings or other pulmonary diseases. Fungal infections accounted
for 46%, mycobacteria for 27%, bacteria for 22%, and parasitic lesions
for 5% of these infections [4].
In conclusion, differentiating of lung TB from neoplasm, ac-
cording to the clinical and radiological ﬁndings can be challenging.
Both diseases present parenchymal inﬁltrates with high metabolic
activity on the 18-FDG-PET scanning and can have similar symp-
toms. On the other hand, the diagnosis of pulmonary TB can be
established with relative simple microbiological tests (direct mi-
croscopy, PCR for mycobacterium complex and cultivation). Inter-
feron gamma release assays for TB detect sensitization to M.
tuberculosis, but on the other hand cannot differentiate between
active and latent TB. Considering TB as one of the differential
diagnosis of PET positive lung inﬁltrate, would help to avoid un-
necessary diagnostic procedures, resulting in reduction of compli-
cations rates and costs of the diagnostic workup.References
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